The immunosuppressive molecule HLA-G and its clinical implications

References

• Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987;84:9145–9149.
   PubMed Web of Science ®Google Scholar
• Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220–223.
   PubMed Web of Science ®Google Scholar
• McMaster MT, Librach CL, Zhou Y et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995;154:3771–3778.
   PubMed Web of Science ®Google Scholar
• Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220–223.
   PubMed Web of Science ®Google Scholar
• Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992;89:3947–3951.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Gonçalves RM-B, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520–11525.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 1997;94:5249–5254.
   PubMed Web of Science ®Google Scholar
• Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999;43:203–211.
   PubMedGoogle Scholar
• LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004;101:7064–7069.
   PubMedGoogle Scholar
• Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005;35:1133–1142.
   PubMed Web of Science ®Google Scholar
• Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004;31:275–278.
   PubMedGoogle Scholar
• Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002;60:122–132.
   PubMed Web of Science ®Google Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000;6:88–95.
   PubMed Web of Science ®Google Scholar
• Farina A, Zucchini C, De Sanctis P et al. Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. Prenat Diagn 2011;31:181–185.
   Google Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C, Hanoch J, Yagel S. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol Hum Reprod 2000;6:535–540.
   Google Scholar
• Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody “87G” and anti-cytokeratin antibody “CAM5.2”. Am J Reprod Immunol 1996;36:349–358.
   PubMed Web of Science ®Google Scholar
• Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004;191:525–529.
   PubMed Web of Science ®Google Scholar
• Shaikly VR, Morrison IE, Taranissi M et al. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J Immunol 2008;180:4330–4337.
   Google Scholar
• Fuzzi B, Rizzo R, Criscuoli L et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311–315.
   PubMedGoogle Scholar
• Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of ‘embryo competency’ and IVF outcome. Reprod Biomed Online 2004;9:74–78.
   PubMed Web of Science ®Google Scholar
• Criscuoli L, Rizzo R, Fuzzi B et al. Lack of Histocompatibility Leukocyte Antigen-G expression in early embryos is not related to germinal defects or impairment of interleukin-10 production by embryos. Gynecol Endocrinol 2005;20:264–269.
   PubMed Web of Science ®Google Scholar
• Sageshima N, Shobu T, Awai K et al. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods. J Reprod Immunol 2007;75:11–22.
   Google Scholar
• Rizzo R, Fuzzi B, Stignani M et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? J Reprod Immunol 2007;74:133–142.
   PubMed Web of Science ®Google Scholar
• Rebmann V, Switala M, Eue I, Grosse-Wilde H. Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study. Hum Reprod 2010;25:1691–1698.
   Google Scholar
• Deschaseaux F, Delgado D, Pistoia V, Giuliani M, Morandi F, Durrbach A. HLA-G in organ transplantation: towards clinical applications. Cell Mol Life Sci 2011;68:397–404.
   PubMed Web of Science ®Google Scholar
• Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006;67:561–567.
   PubMedGoogle Scholar
• Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008;29:29.
   Google Scholar
• Wiendl H, Feger U, Mittelbronn M et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005;128:2689–2704.
   PubMed Web of Science ®Google Scholar
• Borghi A, Fogli E, Stignani M et al. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 2008;300:551–559.
   Google Scholar
• Aractingi S, Briand N, Le Danff C et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001;159:71–77.
   PubMedGoogle Scholar
• Lafon M, Prehaud C, Megret F et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005;79:15226–15237.
   PubMed Web of Science ®Google Scholar
• Yan WH, Lin A, Chen BG, Chen SY. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009;200:820–826.
   Google Scholar
• Lozano JM, González R, Kindelán JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002;16:347–351.
   PubMedGoogle Scholar
• LeBouder F, Khoufache K, Menier C et al. Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 2009;70:1016–1019.
   PubMed Web of Science ®Google Scholar
• Chen HX, Chen BG, Shi WW et al. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 2011;72:159–165.
   Google Scholar
• Paul P, Rouas-Freiss N, Khalil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998;95:4510–4515.
   PubMed Web of Science ®Google Scholar
• Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001;92:369–376.
   PubMed Web of Science ®Google Scholar
• Urosevic M, Kurrer MO, Kamarashev J et al. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001;159:817–824.
   PubMed Web of Science ®Google Scholar
• Davis DM, Reyburn HT, Pazmany L, Chiu I, Mandelboim O, Strominger JL. Impaired spontaneous endocytosis of HLA-G. Eur J Immunol 1997;27:2714–2719.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008;111:4862–4870.
   PubMed Web of Science ®Google Scholar
• Moreau P, Carosella E, Teyssier M et al. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol 1995;43:231–236.
   PubMed Web of Science ®Google Scholar
• Park GM, Lee S, Park B et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 2004;313:606–611.
   PubMed Web of Science ®Google Scholar
• Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007;122:179–188.
   Google Scholar
• Boyson JE, Erskine R, Whitman MC et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002;99:16180–16185.
   Google Scholar
• Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007;37:1924–1937.
   Web of Science ®Google Scholar
• Díaz-Lagares A, Alegre E, Gonzalez A. Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids. Hum Immunol 2009;70:976–980.
   PubMedGoogle Scholar
• McMaster M, Zhou Y, Shorter S et al. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998;160:5922–5928.
   PubMedGoogle Scholar
• Díaz-Lagares A, Alegre E, LeMaoult J, Carosella ED, González A. Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu. Immunology 2009;126:436–445.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Alegre E, Arroyo A, LeMaoult J, Echeveste JI. Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates. Clin Chem 2011;57:1013–1022.
   Google Scholar
• Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011;68:369–395.
   PubMed Web of Science ®Google Scholar
• Le Discorde M, Le Danff C, Moreau P, Rouas-Freiss N, Carosella ED. HLA-G*0105N null allele encodes functional HLA-G isoforms. Biol Reprod 2005;73:280–288.
   PubMedGoogle Scholar
• Matte C, Lacaille J, Zijenah L, Ward B, Roger M. HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol 2000;61:1150–1156.
   Web of Science ®Google Scholar
• Lajoie J, Boivin AA, Jeanneau A, Faucher MC, Roger M. Identification of six new HLA-G alleles with non-coding DNA base changes. Tissue Antigens 2009;73:379–380.
   Google Scholar
• Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003;64:1005–1010.
   PubMed Web of Science ®Google Scholar
• Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004;56:135–141.
   PubMedGoogle Scholar
• Gobin SJ, van den Elsen PJ. Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol 2000;61:1102–1107.
   PubMed Web of Science ®Google Scholar
• Flajollet S, Poras I, Carosella ED, Moreau P. RREB-1 is a transcriptional repressor of HLA-G. J Immunol 2009;183:6948–6959.
   PubMed Web of Science ®Google Scholar
• Yie SM, Xiao R, Librach CL. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod 2006;21:2538–2544.
   PubMed Web of Science ®Google Scholar
• Lefebvre S, Berrih-Aknin S, Adrian F et al. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 2001;276:6133–6139.
   PubMed Web of Science ®Google Scholar
• Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003;13:371–377.
   PubMed Web of Science ®Google Scholar
• Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999;11:803–811.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Hviid TV, Stignani M et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005;57:172–181.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996;156:4224–4231.
   PubMed Web of Science ®Google Scholar
• Sebti Y, Le Maux A, Gros F et al. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol 2007;138:202–212.
   PubMed Web of Science ®Google Scholar
• Blanco O, Tirado I, Muñoz-Fernández R et al. Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization. Hum Reprod 2008;23:144–152.
   Google Scholar
• Moreau P, Faure O, Lefebvre S et al. Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant Proc 2001;33:2277–2280.
   Google Scholar
• Nagamatsu T, Fujii T, Yamashita T et al. Hypoxia does not reduce HLA-G expression on extravillous cytotrophoblasts. J Reprod Immunol 2004;63:85–95.
   Google Scholar
• González-Hernandez A, LeMaoult J, Lopez A et al. Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression. Biol Reprod 2005;73:571–578.
   Google Scholar
• López AS, Alegre E, LeMaoult J, Carosella E, González A. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol Immunol 2006;43:2151–2160.
   PubMed Web of Science ®Google Scholar
• Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J, Carosella ED. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA 2003;100:1191–1196.
   PubMed Web of Science ®Google Scholar
• Poláková K, Bandzuchová E, Kuba D, Russ G. Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines. Leuk Res 2009;33:518–524.
   PubMed Web of Science ®Google Scholar
• Real LM, Cabrera T, Collado A et al. Expression of HLA G in human tumors is not a frequent event. Int J Cancer 1999;81:512–518.
   PubMed Web of Science ®Google Scholar
• Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens 2008;72:137–148.
   PubMedGoogle Scholar
• Zhu XM, Han T, Wang XH et al. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am J Obstet Gynecol 2010;202:592.e1–592.e7.
   Google Scholar
• Tan Z, Randall G, Fan J et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007;81:829–834.
   PubMed Web of Science ®Google Scholar
• Colonna M, Navarro F, Bellón T et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809–1818.
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Cella M et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096–3100.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999;189:1093–1100.
   PubMed Web of Science ®Google Scholar
• Borrego F, Kabat J, Kim DK et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002;38:637–660.
   PubMed Web of Science ®Google Scholar
• Faure M, Long EO. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002;168:6208–6214.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Bryceson YT, Kuppusamy SP et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006;4:e9.
   PubMed Web of Science ®Google Scholar
• Yan WH, Fan LA. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res 2005;15:176–182.
   PubMed Web of Science ®Google Scholar
• Gonen-Gross T, Goldman-Wohl D, Huppertz B et al. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS ONE 2010;5:e8941.
   PubMed Web of Science ®Google Scholar
• Cosman D, Fanger N, Borges L et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997;7:273–282.
   PubMed Web of Science ®Google Scholar
• Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 1997;159:5192–5196.
   PubMed Web of Science ®Google Scholar
• Shiroishi M, Tsumoto K, Amano K et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856–8861.
   PubMed Web of Science ®Google Scholar
• Shiroishi M, Kuroki K, Ose T et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006;281:10439–10447.
   PubMed Web of Science ®Google Scholar
• Shiroishi M, Kuroki K, Rasubala L et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 2006;103:16412–16417.
   PubMedGoogle Scholar
• Gonen-Gross T, Achdout H, Arnon TI et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol 2005;175:4866–4874.
   Google Scholar
• Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000;164:6100–6104.
   PubMed Web of Science ®Google Scholar
• Contini P, Ghio M, Poggi A et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003;33:125–134.
   PubMed Web of Science ®Google Scholar
• Rebmann V, Pfeiffer K, Pässler M et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999;53:14–22.
   PubMed Web of Science ®Google Scholar
• Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007;69 Suppl 1:143–149.
   Google Scholar
• Bensussan A, Gluckman E, el Marsafy S et al. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci USA 1994;91:9136–9140.
   Google Scholar
• Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 2008;9:176–185.
   PubMed Web of Science ®Google Scholar
• Fons P, Chabot S, Cartwright JE et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006;108:2608–2615.
   PubMed Web of Science ®Google Scholar
• Le Rond S, Azéma C, Krawice-Radanne I et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 2006;176:3266–3276.
   PubMed Web of Science ®Google Scholar
• Juch H, Blaschitz A, Daxböck C, Rueckert C, Kofler K, Dohr G. A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains. J Immunol Methods 2005;307:96–106.
   Google Scholar
• Allan DS, Colonna M, Lanier LL et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999;189:1149–1156.
   Google Scholar
• Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001;166:5018–5026.
   PubMed Web of Science ®Google Scholar
• Lesport E, Baudhuin J, Sousa S et al. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer. Cell Mol Life Sci 2011;68:3385–3399.
   Google Scholar
• LeMaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007;109:2040–2048.
   PubMed Web of Science ®Google Scholar
• Caumartin J, Favier B, Daouya M et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007;26:1423–1433.
   PubMed Web of Science ®Google Scholar
• Wiendl H, Mitsdoerffer M, Hofmeister V et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002;168:4772–4780.
   PubMed Web of Science ®Google Scholar
• Lesport E, Baudhuin J, LeMaoult J et al. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell. Hum Immunol 2009;70:1000–1005.
   Google Scholar
• Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001;98:12150–12155.
   PubMed Web of Science ®Google Scholar
• Bahri R, Hirsch F, Josse A et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006;176:1331–1339.
   PubMed Web of Science ®Google Scholar
• Le Friec G, Laupèze B, Fardel O et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 2003;64:752–761.
   PubMed Web of Science ®Google Scholar
• Ketroussi F, Giuliani M, Bahri R, Azzarone B, Charpentier B, Durrbach A. Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway. PLoS ONE 2011;6:e22776.
   PubMedGoogle Scholar
• Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 2010;75:201–206.
   PubMedGoogle Scholar
• Feger U, Tolosa E, Huang YH et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007;110:568–577.
   PubMed Web of Science ®Google Scholar
• Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. J Leukoc Biol 2009;86:273–281.
   PubMedGoogle Scholar
• Huang YH, Zozulya AL, Weidenfeller C et al. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann Neurol 2009;66:171–183.
   PubMed Web of Science ®Google Scholar
• HoWangYin KY, Alegre E, Daouya M, Favier B, Carosella ED, LeMaoult J. Different functional outcomes of intercellular membrane transfers to monocytes and T cells. Cell Mol Life Sci 2010;67:1133–1145.
   Google Scholar
• Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 2011;32:19–25.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liang S, Wu J, Horuzsko A. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 2008;86:1125–1134.
   PubMedGoogle Scholar
• Gregori S, Tomasoni D, Pacciani V et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010;116:935–944.
   PubMed Web of Science ®Google Scholar
• Rossetti M, Gregori S, Roncarolo MG. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells. Eur J Immunol 2010;40:3097–3106.
   Google Scholar
• Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737–742.
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28–50.
   PubMed Web of Science ®Google Scholar
• van der Meer A, Lukassen HG, van Lierop MJ et al. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol Hum Reprod 2004;10:189–195.
   Google Scholar
• van der Meer A, Lukassen HG, van Cranenbroek B et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod 2007;13:123–133.
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005;19:662–664.
   PubMed Web of Science ®Google Scholar
• Pérez-Villar JJ, Melero I, Navarro F et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997;158:5736–5743.
   PubMed Web of Science ®Google Scholar
• Pende D, Sivori S, Accame L et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 1997;27:1875–1880.
   Google Scholar
• Morandi F, Ferretti E, Bocca P, Prigione I, Raffaghello L, Pistoia V. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS ONE 2010;5:e11763.
   Google Scholar
• Morandi F, Ferretti E, Castriconi R et al. Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. Blood 2011;118:5840–5850.
   PubMedGoogle Scholar
• Amiot L, Ferrone S, Grosse-Wilde H, Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell Mol Life Sci 2011;68:417–431.
   PubMed Web of Science ®Google Scholar
• Fainardi E, Castellazzi M, Stignani M et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011;68:433–451.
   Google Scholar
• Moreau P, Carosella E, Gluckman E et al. [Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term]. C R Acad Sci III, Sci Vie 1995;318:837–842.
   Google Scholar
• Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil Steril 1996;65:997–1002.
   Google Scholar
• Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 1996;93:161–165.
   PubMed Web of Science ®Google Scholar
• Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005;175:8379–8385.
   PubMedGoogle Scholar
• Verloes A, Van de Velde H, LeMaoult J et al. HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol 2011;186:2663–2671.
   Google Scholar
• Yie SM, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 2005;83:30–36.
   Google Scholar
• Tabiasco J, Perrier d’Hauterive S, Thonon F et al. Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. Reprod Biomed Online 2009;18:374–381.
   Google Scholar
• Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008;14:209–218.
   Google Scholar
• Ishitani A, Sageshima N, Lee N et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003;171:1376–1384.
   PubMedGoogle Scholar
• Ljunggren HG, Kärre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990;11:237–244.
   PubMedGoogle Scholar
• Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004;64:215–225.
   Google Scholar
• Sun LL, Han Y, Chen JH, Yao YQ. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro. Fertil Steril 2008;90:2398–2405.
   Google Scholar
• Morales PJ, Pace JL, Platt JS et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215–6224.
   PubMed Web of Science ®Google Scholar
• Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol 2005;66:853–863.
   PubMed Web of Science ®Google Scholar
• Solier C, Aguerre-Girr M, Lenfant F et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002;32:3576–3586.
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Fons P, Herault JP et al. Soluble HLA-G and control of angiogenesis. J Reprod Immunol 2007;76:17–22.
   Google Scholar
• McCormick J, Whitley GS, Le Bouteiller P, Cartwright JE. Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod 2009;24:1339–1345.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Jodicke C et al. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009;22:1151–1166.
   PubMed Web of Science ®Google Scholar
• Pfeiffer KA, Rebmann V, Pässler M et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000;61:559–564.
   PubMedGoogle Scholar
• Alegre E, Díaz-Lagares A, Lemaoult J, López-Moratalla N, Carosella ED, González A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol 2007;68:661–667.
   PubMedGoogle Scholar
• Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 1995;154:5665–5674.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682–688.
   PubMed Web of Science ®Google Scholar
• Hackmon R, Hallak M, Krup M et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004;19:404–409.
   PubMed Web of Science ®Google Scholar
• Pace JL, Morales PJ, Phillips TA, Hunt JS. Analysis of the soluble isoforms of HLA-G mRNAs and proteins. Methods Mol Med 2006;122:181–203.
   PubMedGoogle Scholar
• Rizzo R, Stignani M, Amoudruz P et al. Allergic women have reduced sHLA-G plasma levels at delivery. Am J Reprod Immunol 2009;61:368–376.
   Google Scholar
• Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol 2003;23:307–314.
   PubMedGoogle Scholar
• Hackmon R, Koifman A, Hyodo H et al. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007;197:255.e1–255.e5.
   Google Scholar
• Robert-Gangneux F, Gangneux JP, Vu N, Jaillard S, Guiguen C, Amiot L. High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clin Immunol 2011;138:129–134.
   Google Scholar
• Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004;64:66–69.
   PubMed Web of Science ®Google Scholar
• Ober C, Aldrich CL, Chervoneva I et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003;72:1425–1435.
   PubMed Web of Science ®Google Scholar
• Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004;10:237–246.
   PubMed Web of Science ®Google Scholar
• O’Brien M, McCarthy T, Jenkins D et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001;58:1943–1949.
   PubMed Web of Science ®Google Scholar
• Hviid TV, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;55:63–79.
   PubMed Web of Science ®Google Scholar
• Bermingham J, Jenkins D, McCarthy T, O’Brien M. Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia. Biochem Soc Trans 2000;28:215–219.
   PubMed Web of Science ®Google Scholar
• Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D et al. HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 2009;62:25–33.
   Google Scholar
• Yie SM, Li LH, Li GM, Xiao R, Librach CL. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum Reprod 2006;21:46–51.
   PubMed Web of Science ®Google Scholar
• Chauhan M, Balakrishnan M, Yallampalli U et al. Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts. Biol Reprod 2011;85:1232–1239.
   Google Scholar
• Fainardi E, Rizzo R, Melchiorri L et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 2003;142:149–158.
   Google Scholar
• Fainardi E, Rizzo R, Melchiorri L et al. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007;192:219–225.
   Google Scholar
• Waschbisch A, Sandbrink R, Hartung HP et al. Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology 2011;77:596–598.
   Google Scholar
• Barel MT, Ressing M, Pizzato N et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 2003;171:6757–6765.
   Google Scholar
• Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 2010;207:2033–2041.
   Google Scholar
• Pizzato N, Derrien M, Lenfant F. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Hum Immunol 2004;65:1389–1396.
   Google Scholar
• Rivero A, Lozano JM, González R et al. Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. Hum Immunol 2007;68:303–306.
   Google Scholar
• Lozano JM, González R, Luque J, Frias M, Rivero A, Peña J. CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients. Viral Immunol 2009;22:463–465.
   Google Scholar
• Donaghy L, Gros F, Amiot L et al. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol 2007;147:236–240.
   Google Scholar
• Lajoie J, Fontaine J, Tremblay C, Routy JP, Poudrier J, Roger M. Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009;23:1437–1440.
   Google Scholar
• Huang J, Burke P, Yang Y et al. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. J Virol 2010;84:10784–10791.
   Google Scholar
• Lajoie J, Massinga Loembe M, Poudrier J et al. Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. Hum Immunol 2010;71:182–185.
   Google Scholar
• Murdaca G, Contini P, Setti M et al. Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment. Hum Immunol 2011;72:712–716.
   Google Scholar
• Frumento G, Franchello S, Palmisano GL et al. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment. Tissue Antigens 2000;56:30–37.
   PubMed Web of Science ®Google Scholar
• Malmberg KJ, Levitsky V, Norell H et al. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 2002;110:1515–1523.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Bruel S, Menier C, Marcou C, Moreau P, Carosella ED. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis. Int J Cancer 2005;117:114–122.
   Google Scholar
• Langat DK, Sue Platt J, Tawfik O, Fazleabas AT, Hunt JS. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006;71:75–86.
   Google Scholar
• Paul P, Cabestré FA, Le Gal FA et al. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 1999;59:1954–1960.
   PubMed Web of Science ®Google Scholar
• Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 2009;33:633–638.
   Google Scholar
• Mao TL, Kurman RJ, Huang CC, Lin MC, Shih IeM. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 2007;31:1726–1732.
   PubMed Web of Science ®Google Scholar
• Menier C, Prevot S, Carosella ED, Rouas-Freiss N. Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. Hum Immunol 2009;70:1006–1009.
   PubMed Web of Science ®Google Scholar
• He X, Dong DD, Yie SM et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 2010;17:1459–1469.
   PubMed Web of Science ®Google Scholar
• de Kruijf EM, Sajet A, van Nes JG et al. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol 2010;185:7452–7459.
   PubMed Web of Science ®Google Scholar
• Bijen CB, Bantema-Joppe EJ, de Jong RA et al. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer 2010;126:1417–1427.
   PubMed Web of Science ®Google Scholar
• Davidson B, Elstrand MB, McMaster MT et al. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 2005;96:42–47.
   Google Scholar
• Singer G, Rebmann V, Chen YC et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003;9:4460–4464.
   PubMed Web of Science ®Google Scholar
• Zheng N, Wang CX, Zhang X et al. Up-regulation of HLA-G expression in cervical premalignant and malignant lesions. Tissue Antigens 2011;77:218–224.
   PubMedGoogle Scholar
• Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 2007;128:1002–1009.
   PubMed Web of Science ®Google Scholar
• Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007;20:375–383.
   PubMed Web of Science ®Google Scholar
• Du L, Xiao X, Wang C et al. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Sci 2011;102:1272–1280.
   PubMed Web of Science ®Google Scholar
• Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007;14:2721–2729.
   PubMed Web of Science ®Google Scholar
• Ishigami S, Natsugoe S, Miyazono F et al. HLA-G expression in gastric cancer. Anticancer Res 2006;26:2467–2472.
   Google Scholar
• Lin A, Chen HX, Zhu CC et al. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med 2010;14:2162–2171.
   PubMed Web of Science ®Google Scholar
• Cai MY, Xu YF, Qiu SJ et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009;15:4686–4693.
   PubMed Web of Science ®Google Scholar
• Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002;99:609–617.
   PubMed Web of Science ®Google Scholar
• Gros F, Sebti Y, de Guibert S et al. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006;8:223–230.
   PubMed Web of Science ®Google Scholar
• Sebti Y, Le Friec G, Pangault C et al. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 2003;64:1093–1101.
   PubMed Web of Science ®Google Scholar
• Diepstra A, Poppema S, Boot M et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma. Tissue Antigens 2008;71:219–226.
   PubMedGoogle Scholar
• Leleu X, Le Friec G, Facon T et al. Intergroupe Francophone du Myélome. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res 2005;11:7297–7303.
   PubMed Web of Science ®Google Scholar
• Ibrahim EC, Allory Y, Commo F, Gattegno B, Callard P, Paul P. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol 2003;162:501–508.
   Google Scholar
• Ibrahim EC, Aractingi S, Allory Y et al. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer 2004;108:243–250.
   Google Scholar
• Rebmann V, Wagner S, Grosse-Wilde H. HLA-G expression in malignant melanoma. Semin Cancer Biol 2007;17:422–429.
   PubMed Web of Science ®Google Scholar
• Kren L, Muckova K, Lzicarova E et al. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity? J Neuroimmunol 2010;220:131–135.
   PubMed Web of Science ®Google Scholar
• Pangault C, Le Friec G, Caulet-Maugendre S et al. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol 2002;63:83–90.
   Google Scholar
• Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella E, et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007;26:1423–1433.
   PubMed Web of Science ®Google Scholar
• Alegre E, Howangyin KY, Favier B et al. Membrane redistributions through multi-intercellular exchanges and serial trogocytosis. Cell Res 2010;20:1239–1251.
   Google Scholar
• Sayed D, Badr G, Maximous D, Mikhail NN, Abu-Tarboush F, Alhazza IM. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients. Tissue Antigens 2010;75:40–47.
   PubMedGoogle Scholar
• Lin A, Zhu CC, Chen HX et al. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer. J Cell Mol Med 2010;14:2318–2329.
   Google Scholar
• Riteau B, Faure F, Menier C et al. Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 2003;64:1064–1072.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991–998.
   PubMed Web of Science ®Google Scholar
• Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol 2011;33:321–334.
   PubMed Web of Science ®Google Scholar
• Lin A, Zhang X, Xu HH, Xu DP, Ruan YY, Yan WH. HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer. Int J Cancer 2012 (in press)
   Google Scholar
• Zhu CB, Wang CX, Zhang X, Zhang J, Li W. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer 2011;128:617–622.
   PubMed Web of Science ®Google Scholar
• Mach P, Blecharz P, Basta P et al. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis. Am J Reprod Immunol 2010;63:387–395.
   Google Scholar
• Schütt P, Schütt B, Switala M et al. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol 2010;71:489–495.
   PubMed Web of Science ®Google Scholar
• Komohara Y, Harada M, Ishihara Y et al. HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma. Oncol Rep 2007;18:1463–1468.
   Google Scholar
• Michelin S, Gallegos CE, Dubner D, Favier B, Carosella ED. Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line. Hum Immunol 2009;70:1010–1015.
   Google Scholar
• Kleinberg L, Flørenes VA, Skrede M et al. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 2006;449:31–39.
   PubMed Web of Science ®Google Scholar
• Chen HX, Lin A, Shen CJ et al. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol 2010;71:892–898.
   PubMed Web of Science ®Google Scholar
• Barrier BF, Kendall BS, Sharpe-Timms KL, Kost ER. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 2006;103:25–30.
   PubMed Web of Science ®Google Scholar
• Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007;58:267–274.
   PubMed Web of Science ®Google Scholar
• Jung YW, Kim YT, Kim SW et al. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Reprod Sci 2009;16:1103–1111.
   Web of Science ®Google Scholar
• Li BL, Lin A, Zhang XJ et al. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009;74:213–221.
   PubMedGoogle Scholar
• Cao M, Yie SM, Liu J, Ye SR, Xia D, Gao E. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 2011;78:120–128.
   PubMed Web of Science ®Google Scholar